Hologic stock: buy or sell?

HOLX stock price: $49.95 -0.10% At close on September 20th, 2019

Updated on:
September 20th, 2019

4

Hologic shares stayed constant -0.10% to $49.95 today.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally.

Should I buy Hologic stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best moment to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.

None of our preferred buy setups matches with Hologic stock situation right now, therefore this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean HOLX will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Hologic stock a buy?

Financial institutions and banks post stock ratings everyday. At Stocks2.com, we collected 15 ratings published for HOLX stock in the last month.

The general sentiment of these ratings is bullish for HOLX stock, with 10 positive ratings.
Is HOLX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-5Stifel Nicolausn/aHold
2019-8-14Argusn/aBuy
2019-8-1Needham & Company LLCBuyBuy
2019-8-1Needham & Company LLCBuyBuy
2019-8-1Canaccord Genuityn/aHold
2019-8-1BTIG Researchn/aBuy
2019-7-10Needham & Company LLCn/aBuy
2019-4-2Needham & Company LLCn/aBuy
2019-1-7Canaccord Genuityn/aHold
2019-1-4CowenOutperformMarket Perform
2019-1-31Piper Jaffray CompaniesIn-LineOverweight
2019-1-31Needham & Company LLCBuyBuy
2019-1-31BTIG Researchn/aBuy
2019-1-2Morgan StanleyEqual WeightUnderweight
2019-1-14Needham & Company LLCn/aBuy

Hologic stock analysis

Daily outlook

Hologic shares stayed stable -0.10% to $49.95 today.

Hologic shares stayed stable -0.10% to $49.95 today. Since SMA50d and SMA100d crossed up on July, HOLX price climbed $1.45 per share (2.99%). Since June when HOLX stock price broke up the SMA100d line, it gained $4.87 (10.80%). On July, HOLX hit new all time highs, pushing higher previous ATH of $51.57 recorded on July. New ATHs are usual entry points for many trading setups as there aren't higher resistences.

HOLX stock chart (daily)

Weekly outlook

Hologic stayed constant a tiny 0.46% this week. This week was the 4th green week in a row.

Hologic stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Not so far away is the last all-time high Hologic marked late July. Early January HOLX price bounced up over the SMA of 40 weeks that acted as support stopping new slides. By mid July, SMA10w and SMA20w crossed up triggering a rise of 5.56%.

HOLX stock chart (weekly)

Hologic stock price history

Hologic IPO was on March 1st, 1990 at $2.41 per share1. Since then, HOLX stock surged a 1,972.60%, with an average of 68.00% per year. If you had invested right after HOLX's IPO a $1,000 in Hologic stock in 1990, it would worth $19,726.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Hologic stock historical price chart

HOLX stock reached all-time highs on July with a price of $52.19.

Hologic stock price target is $50.50

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We detected 14 price targets for HOLX stock released in the last month:
HOLX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-5Stifel NicolausRaises Target$43.00$48.0011.6%
2019-8-14ArgusRaises Targetn/a$62.00-
2019-8-1Needham & Company LLCReiterates$52.00$57.009.6%
2019-8-1Needham & Company LLCRaises Target$52.00$57.009.6%
2019-8-1Canaccord GenuityReiteratesn/a$52.00-
2019-8-1BTIG ResearchReiteratesn/a$52.00-
2019-7-10Needham & Company LLCReiteratesn/a$52.00-
2019-4-2Needham & Company LLCReiteratesn/a$50.00-
2019-1-7Canaccord GenuityReiteratesn/a$41.00-
2019-1-31Piper Jaffray CompaniesRaises Targetn/a$49.00-
2019-1-31Needham & Company LLCReiterates$48.00$50.004.2%
2019-1-31BTIG ResearchReiteratesn/a$50.00-
2019-1-2Morgan StanleyDowngrades$44.00$39.00-11.4%
2019-1-14Needham & Company LLCReiteratesn/a$48.00-
(in average)$47.80$50.506.0%
The price prediction for Hologic stock is $50.50, moving in a range between $62.00 and $39.00. In average, analysts' outlook on HOLX price forecast is positive, upgrading the target by a 6.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After posting its last earnings report on April, Hologic . Unfortunately, reported EPS is not yet available in our database.
HOLX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q2-n/a0.23n/a
2017-Q32017-11-080.490.52.0%
2017-Q42018-02-080.50.5510.0%
2018-Q12018-05-020.530.530.0%
2018-Q22018-07-310.560.583.6%
2018-Q32018-11-070.590.58-1.7%
2018-Q42019-01-300.570.581.8%
2019-Q12019-04-300.57n/an/a
2019-Q2-n/an/an/a
2019-Q3-n/an/an/a

Annual financial results

In 2018, Hologic annual sales rose a decent 5.20% to $3,217.90 M USD from $3,058.80 marked in 2017. In contrast, its earnings margin (compared to sales) plunged to -3.46%, that is $-111.30 million.

To have an up to date view of the financial situation of Hologic, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Hologic TTM sales up to March 2019 were $3,286.50 and income was $-10.60 million USD. If we compare this TTM figures with the last reported annuality, we can review Hologic business evolution since September 2018: Annual turnover up to March, compared to lastest yearly report, inched a slightly good 2.13%. Likewise, profit margin (net income/revenues) grew at -3.46%.

HOLX annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$2,490 M-$-1,170.00 M-47.0%-
2014$2,531 M1.63%$17 M0.7%-101.48%
2015$2,705 M6.89%$132 M4.9%660.69%
2016$2,833 M4.72%$331 M11.7%151.37%
2017$3,059 M7.98%$756 M24.7%128.39%
2018$3,218 M5.20%$-111.30 M-3.5%-114.73%
TTM $3,287 M2.13%$-10.60 M-0.3%-90.48%

Quarterly financial results

Hologic reported $818.40 million in revenues for 2019-Q1, a -1.48% decline compared to previous quarter. Reported quarter earnings marked $-272.60 M with a profit margin of -33.31%. Profit margin plummed a -45.18% compared to previous quarter when profit margin was 11.87%. When comparing turnover to same quarter last year, Hologic sales marked a good gain and grew a 3.69%.
HOLX quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q2$806 M-$59.50 M7.4%-
2017-Q3$803 M-0.40%$82.70 M10.3%38.99%
2017-Q4$791 M-1.47%$406.70 M51.4%391.78%
2018-Q1$789 M-0.23%$-681.40 M-86.3%-267.54%
2018-Q2$824 M4.40%$112.90 M13.7%-116.57%
2018-Q3$813 M-1.29%$50.50 M6.2%-55.27%
2018-Q4$831 M2.13%$98.60 M11.9%95.25%
2019-Q1$818 M-1.48%$-272.60 M-33.3%-376.47%

Hologic ownership

When you are planning to invest in shares of a company, it's worth to check its ownership structure.

Hologic shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.29% of all shares.

Bearish positions for HOLX stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related companies:

HOLXABTBDXBSXDGX
Market cap$13.4 B$147.9 B$68.5 B$60.2 B$14.5 B
Total shares267.3 M1,770.0 M270.0 M1,390.0 M134.7 M
Float shares266.1 M1,750.0 M269.1 M1,390.0 M134.0 M
  - Institutional holdings (%)99.7%76.5%87.5%93.4%91.5%
  - Insider holdings (%)0.3%0.7%0.3%0.2%0.4%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

Hologic summary

Friday, September 20th, 2019
Open$49.96
Close$49.95
Day range$49.68 - $50.33
Previous close$50.00
Session gain-0.10%
Average true range$0.84
50d mov avg$49.33
100d mov avg$47.94
200d mov avg$46.26
Daily pattern
Weekly pattern lt06a

Hologic performance

To measure stock performance is always good to compare with competitors or related stocks. For Hologic, the benchmark is made against , Becton, Dickinson and, Boston Scientific, Quest Diagnostics, General Electric, , Koninklijke Philips and Thermo Fisher Scientific.
Stock3m6m12m
HOLXHologic1.79%6.62%21.12%
ABT-1.30%8.04%23.06%
BDXBecton, Dickinson...2.85%6.27%-1.81%
BSXBoston Scientific3.84%16.06%14.61%
DGXQuest Diagnostics6.61%21.69%2.68%
GEGeneral Electric-10.42%-5.92%-19.57%
JNJ-7.74%-3.60%-6.42%
PHGKoninklijke Phili...12.83%25.47%8.50%
TMOThermo Fisher Sci...0.70%12.47%22.04%

Hologic competitors

One check before trading any stock is to review a list of its competitors, in this case for Hologic. We picked 8 companies as Hologic competitors as they are in the same industry or have similar market objectives.

Latest Hologic stock news